Cargando…

Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is common in heart failure (HF) and is associated with worse prognosis. In this review, we discuss the cardiovascular e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neves, João Sérgio, Vale, Catarina, von Hafe, Madalena, Borges-Canha, Marta, Leite, Ana Rita, Almeida-Coelho, João, Lourenço, André, Falcão-Pires, Inês, Carvalho, Davide, Leite-Moreira, Adelino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543162/ https://www.ncbi.nlm.nih.gov/pubmed/33088475 http://dx.doi.org/10.1177/2042018820958331

Ejemplares similares

OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
por: Almeida-Coelho, João, et al.
Publicado: (2022)

The impact of thyroid hormone dysfunction on ischemic heart disease
por: von Hafe, Madalena, et al.
Publicado: (2019)

Evaluation of Thyroid Function in Patients Hospitalized for Acute Heart Failure
por: Leite, Ana Rita, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review
por: Von-Hafe, Madalena, et al.
Publicado: (2022)

RF36 | PSUN101 Liver and Adipose Tissue Effects of Triiodothyronine Treatment in an Animal Model of Metabolic Syndrome
por: Canha, Marta Borges, et al.
Publicado: (2022)

Association of thyroid function, within the euthyroid range, with cardiovascular risk: The EPIPorto study
por: Neves, João Sérgio, et al.
Publicado: (2022)

MON-587 Thyroid Hormones within the Normal Range and Cardiac Function in the General Population: The Epiporto Study
por: Neves, João Sérgio, et al.
Publicado: (2019)

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
por: Neves, João Sérgio, et al.
Publicado: (2022)

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction
por: Sebastião, Maria J., et al.
Publicado: (2022)

Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
por: Vaz-Salvador, Pedro, et al.
Publicado: (2022)

Physiologic Basis and Pathophysiologic Implications of the Diastolic Properties of the Cardiac Muscle
por: Ferreira-Martins, João, et al.
Publicado: (2010)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Gender Differences in Predictors and Long-Term Mortality of New-Onset Postoperative Atrial Fibrillation Following Isolated Aortic Valve Replacement Surgery
por: Fragão-Marques, Mariana, et al.
Publicado: (2020)

Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
por: van Heerebeek, Loek, et al.
Publicado: (2013)

Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2021)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Myocardial stretch-induced compliance is abrogated under ischemic conditions and restored by cGMP/PKG-related pathways
por: Leite-Moreira, André M., et al.
Publicado: (2023)

Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk‐related rat model of heart failure with preserved ejection fraction
por: Miranda‐Silva, Daniela, et al.
Publicado: (2019)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2021)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Impact of Updated Guidelines on Diastolic Dysfunction in Patients with Preserved Ejection Fraction
por: Yoon, Hyun Ju
Publicado: (2021)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis
por: Fragão-Marques, Mariana, et al.
Publicado: (2021)

Acute Myocardial Response to Stretch: What We (don't) Know
por: Neves, João S., et al.
Publicado: (2016)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

A Case of Postpartum Pulmonary Edema With Preserved Ejection Fraction and Diastolic Capacity
por: Tanabe, Shohei, et al.
Publicado: (2022)

Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?
por: Portela-Cidade, José Pedro, et al.
Publicado: (2015)

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
por: Inácio, José M., et al.
Publicado: (2023)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction
por: Fuchida, Aya, et al.
Publicado: (2021)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction
por: Kim, Myung Yoon, et al.
Publicado: (2023)

Pericardial Fluid Annexin A1 Is a Marker of Atrial Fibrillation in Aortic Stenosis: A Proteomics Analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2022)

Diastolic dysfunction in patients with preserved ejection fraction: identification by velocity encoded magnetic resonance imaging
por: Radunski, Ulf K, et al.
Publicado: (2011)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng, Huan, et al.
Publicado: (2014)

The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017)

Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
por: Coculescu, Bogdan Ioan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q8711r7olo0eu1nrgjesc8hgn8